See All Slides - tctmd.com

Slides

Presentation

Case 2: Patient Post-DES Requiring Noncardiac Surgery

Presenter: Ajay Kirtane

October 29, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

Vascular and Bleeding Complications

Presenter: James Hermiller Jr

October 29, 2013

Presentation TCT 2013

All Novel Agents are Preferred to Warfarin

Presenter: Michael Ezekowitz

October 29, 2013

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation

The Rostock/Berlin Real World Experience

Presenter: Stephan Kische

October 29, 2013

Presentation TCT 2013

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

Presenter: Hong-Seok Lim

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for SIHD: Strengths, Limitations, and Evolution of Terminology and Process

Presenter: Manesh Patel

October 29, 2013

Advertisement

Slides

Case 2: Patient Post-DES Requiring Noncardiac Surgery

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Vascular and Bleeding Complications

All Novel Agents are Preferred to Warfarin

Silent Atrial Fibrillation: An Under-Appreciated Threat

The Rostock/Berlin Real World Experience

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Appropriateness Use Criteria Recommendations for SIHD: Strengths, Limitations, and Evolution of Terminology and Process

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content